FRANCIS OKAFOR: Open Payments
NPI 1093457111 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$613 in 16 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $258 · 2025 $613
Food & beverage: $613
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 9 | $311 |
| ACADIA Pharmaceuticals Inc | 1 | $109 |
| Alkermes, Inc. | 2 | $59 |
| E.R. Squibb & Sons, L.L.C. | 1 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
| Neurocrine BioSciences, Inc. | 1 | $30 |
Products named: AUSTEDO XR, NUPLAZID, ARISTADA, COBENFY, INGREZZA, REXULTI, ABILIFY MAINTENA.
Industry payments across KS — which companies pay providers there.
